Ekso Bionics Files 8-K on Agreements and Obligations

TL;DR

Ekso Bionics 8-K: Material agreements entered and terminated, new financial obligations created. Watch closely.

AI Summary

Ekso Bionics Holdings, Inc. filed an 8-K on September 17, 2025, reporting the entry into and termination of material definitive agreements, as well as the creation of direct financial obligations. The filing covers events occurring on or before September 12, 2025.

Why It Matters

This filing indicates significant changes in Ekso Bionics' contractual and financial commitments, which could impact its operational and financial standing.

Risk Assessment

Risk Level: medium — The simultaneous entry into and termination of material agreements, along with new financial obligations, suggests potential volatility or restructuring within the company.

Key Players & Entities

• Ekso Bionics Holdings, Inc. (company) — Registrant
• September 12, 2025 (date) — Earliest event reported
• September 17, 2025 (date) — Date of report

FAQ

Key Financial Figures

• $0.001 — ge on which registered Common Stock , $0.001 par value per share EKSO NASDAQ Capi
• $2.0 million — an aggregate principal amount of up to $2.0 million. The proceeds of the loan under the Agr
• $2.4 million — atures on the earlier of the receipt of $2.4 million in net proceeds from the sale of the eq
• $200,000 — e loan, which shall in the aggregate be $200,000 (the "Exit Fee"). The Company may prepa

Filing Documents

• ekso20250917_8k.htm (8-K) — 33KB
• ex_862299.htm (EX-10.1) — 119KB
• 0001437749-25-029285.txt ( ) — 316KB
• ekso-20250917.xsd (EX-101.SCH) — 3KB
• ekso-20250917_def.xml (EX-101.DEF) — 11KB
• ekso-20250917_lab.xml (EX-101.LAB) — 15KB
• ekso-20250917_pre.xml (EX-101.PRE) — 11KB
• ekso20250917_8k_htm.xml (XML) — 3KB

01

Item 1.01 Entry into a Material Definitive Agreement. On September 12, 2025, Ekso Bionics Holdings, Inc. (the "Company") entered into a Secured Promissory Note and Security Agreement (the "Agreement"), by and among the Company, Ekso Bionics, Inc., a Delaware corporation and subsidiary of the Company (the "Subsidiary"), as guarantor, and B. Riley Commercial Capital, LLC, as lender (the "Lender"). The Agreement provides for a secured term loan in an aggregate principal amount of up to $2.0 million. The proceeds of the loan under the Agreement may be used for working capital for operations and other general corporate purposes. The loan matures on the earlier of the receipt of $2.4 million in net proceeds from the sale of the equity interests of the Company from new equity investors (a "Qualified Financing") or September 14, 2026 (the "Maturity Date"). Borrowings under the Agreement bear interest at the rate of 10.0% per annum, which shall be payable in full on the Maturity Date. On the Maturity Date, the Company shall pay to the Lender an exit fee in the amount of 10% of the original principal amount of the loan, which shall in the aggregate be $200,000 (the "Exit Fee"). The Company may prepay the obligations under the Agreement at any time in whole in part; provided, that the Company pays all accrued but unpaid interest on such portion of the principal prepaid, all interest that would have accrued through the Maturity Date on such principal amount prepaid and the portion of the Exit Fee applicable to such principal amount prepaid. The Lender may elect to convert the obligations under the Agreement, including the principal, interest and Exit Fee, into equity securities of the Company in connection with a Qualified Financing at the purchase price per share paid by the lead investor thereunder. The obligations under the Agreement are required to be guaranteed by the Subsidiary and secured by substantially all of the personal property of the Company and the Subsidia

02

Item 1.02 Termination of a Material Definitive Agreement. On September 12, 2025, in connection with the entry into the Agreement, the Company paid off all obligations under and terminated that Loan and Security Agreement, dated as of August 17, 2020, by and between the Company, the Subsidiary and Banc of California, a California state-chartered bank (formerly known as Pacific Western Bank), which provided for a loan in an aggregate principal amount of $2.0 million.

03

Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The information set forth under Item 1.01 of this Current Report on Form 8-K is incorporated by reference into this Item 2.03.

Financial Statements and Exhibits

Financial Statements and Exhibits. (d) Exhibits Exhibit Description 10.1 Secured Promissory Note and Security Agreement, dated as of September 12, 2025, by and among Ekso Bionics Holdings, Inc. as the borrower, Ekso Bionics, Inc., as guarantor, and B. Riley Commercial Capital, LLC, as lender. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. EKSO BIONICS HOLDINGS, INC. By: /s/ Jerome Wong Name: Jerome Wong Title: Chief Financial Officer Dated: September 17, 2025

View Full Filing

View this 8-K filing on SEC EDGAR